Highlights and Quick Summary
- EBT for the quarter ending September 30, 2022 was $-81.7 Million (a 13.5% increase compared to previous quarter)
- Year-over-year quarterly EBT increased by 26.21%
- Annual EBT for 2021 was $-371 Million (a 90.47% increase from previous year)
- Annual EBT for 2020 was $-195 Million (a 148.44% increase from previous year)
- Annual EBT for 2019 was $-78.3 Million (a -32.9% decrease from previous year)
- Twelve month EBT ending September 30, 2022 was $-288 Million (a 22.88% increase compared to previous quarter)
- Twelve month trailing EBT decreased by -22.42% year-over-year
Trailing EBT for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $-288 Million | $-234 Million | $-238 Million | $-371 Million |
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBT of Beam Therapeutics Inc.
Most recent EBTof BEAM including historical data for past 10 years.Interactive Chart of EBT of Beam Therapeutics Inc.
Beam Therapeutics Inc. EBT for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $-81.67 | $-71.95 | $-69.21 | – |
| 2021 | $-64.71 | $-28.12 | $-76.25 | $-201.56 | $-370.64 |
| 2020 | $-95.46 | $-34.45 | $-34.22 | $-30.46 | $-194.59 |
| 2019 | $-27.85 | $-19.01 | $-17.86 | $-13.61 | $-78.33 |
| 2018 | – | – | – | – | $-116.74 |
| 2017 | – | – | – | – | $-8.0 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology